May 16, 2022 | Blog, Shareholder Investigations
Kehoe Law Firm, P.C. is investigating whether certain executive officers or directors of Osprey Technology Acquisition Corp. (“Osprey”), now known as BlackSky Technology Inc. (“BlackSky Technology”) (NYSE: BKSY), breached their fiduciary duties of disclosure, candor, and requirements to act in good faith, and whether Osprey’s shareholders suffered damages as a result.
INVESTORS OF BLACKSKY TECHNOLOGY STOCK WHO PREVIOUSLY HELD OSPREY SECURITIES ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS OF THEIR STOCK HOLDINGS.
On September 8, 2021, Osprey shareholders of record, as of July 16, 2021, approved a merger between Osprey and BlackSky Technology. After the merger, BlackSky Technology announced that it missed the forecast in the merger proxy for full-year net profit by roughly $200 million. The stock price has declined by over 85% since the merger.
BLACKSKY TECHNOLOGY SHAREHOLDERS WHO HELD OSPREY STOCK ARE ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE BREACH OF FIDUCIARY DUTIES INVESTIGATION AND POTENTIAL LEGAL CLAIMS.
Apr 13, 2022 | Blog, Shareholder Investigations
Kehoe Law Firm, P.C. is investigating whether certain directors and officers of TransUnion (NYSE: TRU) breached their fiduciary duties to TransUnion and its shareholders.
TransUnion shareholders who have held their TransUnion stock for at least a year or more are encouraged to CLICK HERE to contact Kehoe Law Firm, P.C. and provide details of their TransUnion holdings.
TransUnion shareholders should be aware that the Consumer Financial Protection Bureau (“CFPB”) announced the filing of a lawsuit against TransUnion, two of its subsidiaries, and executive John Danaher for violating a 2017 law enforcement order. The order was issued to stop TransUnion from engaging in deceptive marketing regarding its credit scores and other credit-related products.
After the order went into effect, TransUnion, according to the CFPB continued its unlawful behavior, disregarded the order’s requirements, and continued employing deceitful digital dark patterns to profit from customers. The CFPB’s complaint also alleges that TransUnion violated additional consumer financial protection laws.
Apr 12, 2022 | Blog, Shareholder Investigations
Did Fusion Acquisition’s Board of Directors or Executive Officers Breach Their Fiduciary Duties to Fusion’s Shareholders?
Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Fusion Acquisition Corp. (“Fusion”), now known as MoneyLion Inc. (“MoneyLion”) (NYSE: ML), breached their fiduciary duties to Fusion’s shareholders.
INVESTORS OF FUSION STOCK PRIOR TO THE MERGER WITH MONEYLION WHO CONTINUE TO HOLD MONEYLION STOCK SHARES ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C. AND PROVIDE DETAILS OF THEIR MONEYLION/FUSION SECURITIES.
The investigation concerns whether Fusion’s board of directors or executive officers breached their duties of disclosure, requirements to act in good faith, and whether former Fusion’s shareholders suffered damages as a result.
On September 21, 2021, Fusion shareholders of record as of September 2, 2021, approved a merger between Fusion and MoneyLion. MoneyLion has reported that it is under investigation by numerous federal and state regulators. Immediately after the merger, MoneyLion’s stock price dropped significantly.
At the close of trading on April 12, 2022, the stock price of MoneyLion was $2.12 per share.
FORMER INVESTORS OF FUSION ACQUISITION SECURITIES WHO CONTINUE TO HOLD MONEYLION STOCK MAY HAVE LEGAL CLAIMS AND ARE ENCOURAGED TO CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE INVESTIGATION AND POTENTIAL LEGAL CLAIMS.
Apr 11, 2022 | Blog, Shareholder Investigations
Anaplan Shareholders May Have Legal Claims in Connection with the Announced Buyout of Anaplan by Thoma Bravo
Kehoe Law Firm, P.C. is investigating whether the directors of Anaplan, Inc. (“Anaplan”) (NYSE: PLAN) breached their fiduciary duties to its shareholders in approving a buyout with Thoma Bravo LP for inadequate consideration.
ANAPLAN SHAREHOLDERS ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM AND PROVIDE INFORMATION ABOUT THEIR ANAPLAN SECURITIES.
On March 20, 2022, Anaplan announced it had reached an agreement to be bought out by Thoma Bravo for $66.00 per share, in an all-cash transaction valued at $10.7 billion.
The investigation concerns whether Anaplan’s board of directors failed to maximize the value of Anaplan for the benefit of Anaplan’s shareholders in connection with its announced buyout by Thoma Bravo, in breach of their fiduciary duties to Anaplan’s shareholders, and whether Anaplan’s shareholders have suffered damages as a result.
Anaplan shareholders are also encouraged to contact John Kehoe, Esq., (215) 792-6676, Ext. 801, [email protected], [email protected], to discuss the investigation and for a no-obligation evaluation of potential legal claims.
Apr 7, 2022 | Blog, Shareholder Investigations
Mullen Automotive Investors with Financial Losses Encouraged to Contact Kehoe Law Firm, P.C. – Mullen Automotive is “Another Fast Talking EV Hustle,” According to Hindenburg Research.
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Mullen Automotive, Inc. (“Mullen Automotive” or the “Company”) (NASDAQ: MULN).
Investors of Mullen Automotive with investment losses are encouraged to contact Kehoe Law Firm, P.C. and provide details of their stock losses by CLICKING HERE.
In an April 6, 2022 research report, “Mullen Automotive: Yet Another Fast Talking EV Hustle,” Hindenburg Research reported, among other things, that “Mullen is an aspiring EV manufacturer that came public in late 2021 via reverse merger. It has yet to produce a sellable vehicle.”
Hindenburg Research also reported that “[d]espite only spending ~$3 million in R&D in 2021, Mullen claims its solid-state battery technology is on track for commercialization in 18 to 24 months, putting it head of every major technology and automaker in the industry who have collectively invested billions on solving the problem.”
According to Hindenburg Research, “Mullen recently press released an update on its battery testing, sending its stock soaring 145% in a day. In reality, the ‘news’ appears to be a rehash of testing the company had already announced in 2020[,] and “Mullen apparently misrepresented the test results, according to the CEO of the company that performed the tests. Its CEO told [Hindenburg Research] of Mullen’s press release: ‘We never would have said that. We never did say it and certainly wouldn’t have said it based on the results of testing that battery.'”
Additionally, Hindenburg Research reported that it has “. . . seen this story before, but Mullen strikes us as one of the worst. With echoes of Nikola, Lordstown, Kandi and Ideanomics, we think Mullen is just the latest in a long line of EV hustles.”
On this news, Mullen Automotive’s stock price dropped significantly and was down during intraday trading on April 7, 2022.
Mullen Automotive shareholders are also encouraged to contact John Kehoe, Esq., (215) 792-6676, Ext. 801, [email protected], [email protected], to discuss the securities investigation and for a free, no-obligation evaluation of potential legal claims.
Mar 30, 2022 | Shareholder Investigations
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of UpHealth, Inc. (“UpHealth” or the “Company”) (NYSE: UPH).
If you purchased, or otherwise acquired, UpHealth stock and lost money, please CLICK HERE to contact Kehoe Law Firm, P.C. and provide details about your UPH stock losses.
In a March 30, 2022 press release, UpHealth announced that “[o]n March 25, 2022, the Audit Committee of the Board of Directors of UpHealth, after considering the recommendations of management, concluded that the Company’s condensed consolidated financial statements included in the Company’s Quarterly Report on Form 10-Q for the three and nine month periods ended September 30, 2021 (the ‘Non-Reliance Periods’) as previously filed with the SEC should not be relied upon because of errors identified therein . . . .”
UpHealth also reported that “[t]he error that caused the Company to conclude that its financial statements and other financial information for the Non-Reliance Periods should not be relied upon was the result of an incorrect accounting conclusion regarding a contract with a customer, which resulted in the incorrect recognition of revenue during the Non-Reliance Period.”
On this news, UpHealth stock was down almost 30% during intraday trading on March 30, 2022.
